Company Filing History:
Years Active: 2011-2013
Title: Tetsushi Kawahara: Innovator in Antibody Research
Introduction
Tetsushi Kawahara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 5 patents to his name, Kawahara's work has the potential to impact medical treatments significantly.
Latest Patents
Kawahara's latest patents include groundbreaking inventions such as a polynucleotide encoding an anti-CD14 antibody fusion protein. This invention features a protein that comprises an anti-CD antibody or its active fragment, along with an inhibitor for a protease. Another notable patent is for an anti-platelet membrane glycoprotein VI monoclonal antibody. This antibody specifically binds to human platelet membrane glycoprotein VI (GPVI) while maintaining low activation functions for platelets and partially depleting GPVI on the platelet membrane.
Career Highlights
Kawahara has established a successful career at Mochida Pharmaceutical Co., Ltd., where he continues to innovate in the field of antibody research. His work is characterized by a commitment to advancing therapeutic options for patients.
Collaborations
Throughout his career, Kawahara has collaborated with esteemed colleagues such as Shoji Furusako and Yoshitaka Hosaka. These partnerships have fostered a collaborative environment that enhances the research and development of new medical therapies.
Conclusion
Tetsushi Kawahara is a distinguished inventor whose work in antibody research is paving the way for new medical advancements. His innovative patents and collaborations reflect his dedication to improving healthcare solutions.